145 related articles for article (PubMed ID: 35522155)
1. The prognostic value of stromal tumor-infiltrating lymphocytes in intrahepatic cholangiocarcinoma: a population-based study.
Qiang Z; Dai K; He Y; Yang Z; Tao L; Zhang H; Yu H
Scand J Gastroenterol; 2022 Aug; 57(8):965-971. PubMed ID: 35522155
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
Vigano L; Soldani C; Franceschini B; Cimino M; Lleo A; Donadon M; Roncalli M; Aghemo A; Di Tommaso L; Torzilli G
J Gastrointest Surg; 2019 Nov; 23(11):2216-2224. PubMed ID: 30843133
[TBL] [Abstract][Full Text] [Related]
3. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
5. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.
Miyazaki K; Morine Y; Yamada S; Saito Y; Tokuda K; Okikawa S; Yamashita S; Oya T; Ikemoto T; Imura S; Hu H; Morioka H; Tsuneyama K; Shimada M
Int J Clin Oncol; 2021 Dec; 26(12):2265-2274. PubMed ID: 34596803
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma.
Lan C; Kitano Y; Yamashita YI; Yamao T; Kajiyama K; Yoshizumi T; Fukuzawa K; Sugimachi K; Ikeda Y; Takamori H; Miyanari N; Hirota M; Baba H
Br J Cancer; 2022 Feb; 126(2):219-227. PubMed ID: 34616011
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.
Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
Mod Pathol; 2021 Apr; 34(4):798-807. PubMed ID: 33077921
[TBL] [Abstract][Full Text] [Related]
9. Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment.
Toshida K; Itoh S; Nakayama Y; Tsutsui Y; Kosai-Fujimoto Y; Tomino T; Yoshiya S; Nagao Y; Harada N; Kohashi K; Oda Y; Yoshizumi T
Int J Clin Oncol; 2023 Aug; 28(8):1082-1091. PubMed ID: 37247134
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
12. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma.
Yugawa K; Itoh S; Yoshizumi T; Morinaga A; Iseda N; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
Int J Clin Oncol; 2021 Oct; 26(10):1901-1910. PubMed ID: 34117554
[TBL] [Abstract][Full Text] [Related]
15. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
[TBL] [Abstract][Full Text] [Related]
16. High Visceral Fat is Associated with a Worse Survival after Liver Resection for Intrahepatic Cholangiocarcinoma.
Lacaze L; Bergeat D; Rousseau C; Sulpice L; Val-Laillet D; Thibault R; Boudjema K
Nutr Cancer; 2023; 75(1):339-348. PubMed ID: 36052974
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
19. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
[TBL] [Abstract][Full Text] [Related]
20. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]